Rx Cost-Effectiveness Beyond Medicare: Merck, AARP Plan Policy Meeting
Executive Summary
Merck and AARP are working with the Agency for Healthcare Research & Quality to organize a "stakeholders" meeting to discuss standards for cost-effectiveness research
You may also be interested in...
PhRMA Adopts Outcomes Research Policy; Set For Cost-Effectiveness Debate
Government-supported health outcomes research must recognize the benefits of multiple treatment options, the Pharmaceutical Research & Manufacturers of America's principles on outcomes research say
Cost-effectiveness research
Merck/AARP "invitation only" conference on cost-effectiveness/outcomes research is set for Jan. 28. The stakeholders meeting, which will include the Agency for Healthcare Research & Quality as a key participant, will attempt to develop a consensus on standards for research. Wharton Health Care Systems Department Chairman Mark Pauly, MD, will moderate the meeting (1"The Pink Sheet" Nov. 10, 2003, p. 3). The Pharmaceutical Research & Manufacturers of America is expected to discuss a position on outcomes research during its next board meeting, Jan. 15...
Cost-effectiveness research
Merck/AARP "invitation only" conference on cost-effectiveness/outcomes research is set for Jan. 28. The stakeholders meeting, which will include the Agency for Healthcare Research & Quality as a key participant, will attempt to develop a consensus on standards for research. Wharton Health Care Systems Department Chairman Mark Pauly, MD, will moderate the meeting (1"The Pink Sheet" Nov. 10, 2003, p. 3). The Pharmaceutical Research & Manufacturers of America is expected to discuss a position on outcomes research during its next board meeting, Jan. 15...